Literature DB >> 11784225

Changing patient characteristics and the effect on mortality in endocarditis.

Christopher H Cabell1, James G Jollis, Gail E Peterson, G Ralph Corey, Deverick J Anderson, Daniel J Sexton, Christopher W Woods, L Barth Reller, Thomas Ryan, Vance G Fowler.   

Abstract

BACKGROUND: Limited data exist on recent demographic and microbiological changes in infective endocarditis (IE) and the impact of these changes on patient survival.
METHODS: Data were collected from all patients with definite or possible IE at Duke University Medical Center, Durham, NC, from 1993 to 1999. Logistic regression analysis was used to identify demographic and microbiological changes that occurred in patients with IE over the study period. The impact of these changes on survival was evaluated using Cox proportional hazards modeling.
RESULTS: Among the 329 study patients, rates of hemodialysis dependence, immunosuppression, and Staphylococcus aureus infection increased during the study period (P=.04, P=.008, and P<.001, respectively), while rates of infection due to viridans group streptococci decreased (P=.007). Hemodialysis was independently associated with S aureus infection (odds ratio, 3.1; 95% confidence interval, 1.6-5.9). Patients with S aureus IE had a higher 1-year mortality rate (43.9% vs 32.5%; P=.04) that persisted after adjustment for other illness severity characteristics (hazard ratio, 1.5; 95% confidence interval, 1.03-2.3).
CONCLUSIONS: The demographic and microbiological characteristics of IE at our institution have changed over the past decade in ways that suggest a link between medical practice and IE characteristics. Staphylococcus aureus has emerged as a dominant cause of IE, and is an independent predictor of mortality. These findings identify clinical settings that may warrant closer surveillance and more aggressive measures in the identification and prevention of endocarditis.

Entities:  

Mesh:

Year:  2002        PMID: 11784225     DOI: 10.1001/archinte.162.1.90

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  112 in total

1.  Diagnosis of infective endocarditis.

Authors:  Bernard D Prendergast
Journal:  BMJ       Date:  2002-10-19

2.  Cardiac Microlesions Form During Severe Bacteremic Enterococcus faecalis Infection.

Authors:  Armand O Brown; Kavindra V Singh; Melissa R Cruz; Karan Gautam Kaval; Liezl E Francisco; Barbara E Murray; Danielle A Garsin
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

Review 3.  Diagnostic criteria and problems in infective endocarditis.

Authors:  B D Prendergast
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

4.  A survey on the use of gentamicin in infective endocarditis.

Authors:  G Béraud; G Le Moal; A Elsendoorn; P Tattevin; C Godet; S Alfandari; W Couet; P Roblot; F Roblot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-29       Impact factor: 3.267

5.  Update on echocardiography in the management of infective endocarditis.

Authors:  John Francis Sedgwick; Darryl John Burstow
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

6.  Risk factors of mid-term mortality of patients with infective endocarditis.

Authors:  A Nomura; F Omata; K Furukawa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-17       Impact factor: 3.267

Review 7.  Infective endocarditis.

Authors:  Rhys P Beynon; V K Bahl; Bernard D Prendergast
Journal:  BMJ       Date:  2006-08-12

Review 8.  Infective endocarditis: therapeutic options and indications for surgery.

Authors:  Aneil Malhotra; Jenny Rayner; Timothy M Williams; Bernard Prendergast
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

9.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

10.  Neurologic complications of infective endocarditis.

Authors:  Amy A Pruitt
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.